Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Research Fix-Corp Int'l (BB:FIXC). -- Ignore unavailable to you. Want to Upgrade?

To: Benchman who wrote (1595)	3/25/1998 10:36:00 AM
From: wmwmw	Read Replies (1) \| Respond to of 1845

HCFA to Withdraw Medicare Non-Coverage Policy Proposed For the Salitron(R) System FORT WASHINGTON, Pa., March 25 /PRNewswire/ -- Biosonics, Inc. (OTC Bulletin Board: BISN - news) announces that on Tuesday, March 10, 1998, during a hearing held by the Senate Appropriations Subcommittee on Labor, Health and Human Services, and Education, HCFA Administrator Nancy Ann DeParle stated her intention to withdraw the May 23, 1994, Federal Register notice which proposed a national Medicare non-coverage policy for the Salitron(R). Her statement was made in response to a question concerning the status of the Agency's review of new information submitted by Biosonics in support of an affirmative national coverage determination. A final decision on coverage of the Salitron remains under review by the Agency. To date approximately forty-four private insurance carriers have reimbursed patient usage of the Salitron. The Salitron is a portable, battery operated therapeutic device used by patients suffering from dry mouth secondary to Sjogren's Syndrome, an auto immune disease. Medicare coverage would enable patients over 65 that suffer from this condition the means to utilize the Salitron. Although dry mouth is not a ''killer'' disease, its devastating effect substantially reduces the patients' quality of life. Medicare coverage would enable Biosonics to meet the needs of these patients who have very few effective alternative long term treatments available. Biosonics has developed several patented devices that counteract body malfunctions of which four have received FDA approval to market. In addition to the SALITRON(R) mentioned above they are the CYSTOTRON(TM) for urinary incontinence, the ANOTRON(TM) for fecal incontinence and the BIDDS(TM) GLOVE used by physicians as a diagnostic tool for the Cystotron and Anotron. Contact Jack Paller at 215-646-7100, or our web site ''www.biosonics.com'' for more information. SOURCE: Biosonics, Inc.

To: Benchman who wrote (1595)	3/25/1998 10:43:00 PM
From: bubba001	Read Replies (1) \| Respond to of 1845

Bubba STOCK ALERT>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> As I stated last week AGTI and IMUTF are going to move!!!! Check last weeks posts to verify!! I don't mess up stock symbols like some do. AGTI - News out with SEGA 09:35. Stock traded 7 mil+ shares and should move into the .25 area by weeks end. Get in early tomorrow!!! This news is one of several to come in next 30 days. IMUTF - News out 17:35 - Get in before 10:30 tomorrow. stock should run. Up 1/32 on 3,900 vol. Wed. News should hit BIG!!!! This is an up and coming company. Look for more Bubba's Tip SOON. Bubba